These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22334364)

  • 1. [Primary systemic vasculitides].
    Schinke S; Herlyn K; Holle JU; Gross WL
    Dtsch Med Wochenschr; 2012 Feb; 137(8):373-84; quiz 385-6. PubMed ID: 22334364
    [No Abstract]   [Full Text] [Related]  

  • 2. Systemic vasculitis.
    Sharma P; Sharma S; Baltaro R; Hurley J
    Am Fam Physician; 2011 Mar; 83(5):556-65. PubMed ID: 21391523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
    De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
    Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GI vasculitis associated with systemic lupus erythematosus.
    Lee CK; Lee TH; Lee SH; Chung IK; Park SH; Kim HS; Kim SJ
    Gastrointest Endosc; 2010 Sep; 72(3):618-9. PubMed ID: 20541196
    [No Abstract]   [Full Text] [Related]  

  • 5. Urticarial vasculitis in systemic lupus erythematosus: fair response to prednisolone/dapsone and persistent hypocomplementemia.
    Nishijima C; Hatta N; Inaoki M; Sakai H; Takehara K
    Eur J Dermatol; 1999; 9(1):54-6. PubMed ID: 9920991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of urotoxic adverse events in cyclophosphamide-treated patients with systemic necrotizing vasculitides.
    Le Guenno G; Mahr A; Pagnoux C; Dhote R; Guillevin L;
    Arthritis Rheum; 2011 May; 63(5):1435-45. PubMed ID: 21337321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary systemic vasculitis.
    Day C; Savage C
    Minerva Med; 2001 Oct; 92(5):349-63. PubMed ID: 11675579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sarcoidosis with cutaneous granulomatous vasculitis.
    Wei CH; Huang YH; Shih YC; Tseng FW; Yang CH
    Australas J Dermatol; 2010 Aug; 51(3):198-201. PubMed ID: 20695860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate in resistant ENL.
    Kar BR; Babu R
    Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):480-2. PubMed ID: 15755203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
    Reinhold-Keller E
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1909-10. PubMed ID: 12226791
    [No Abstract]   [Full Text] [Related]  

  • 11. [Skin diseases due to systemic vasculitides and vasculopathies].
    Volc S; Maier JC; Röcken M
    Hautarzt; 2016 Dec; 67(12):948-959. PubMed ID: 27864582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
    Collis CH
    Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
    [No Abstract]   [Full Text] [Related]  

  • 13. Childhood systemic vasculitis.
    Sag E; Batu ED; Ozen S
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):558-575. PubMed ID: 29773273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Case report; a case of microscopic polyangitis presenting with acute tubulointerstitial nephritis].
    Tagawa S; Kasahara H; Shimizu Y; Otomo K; Koike T
    Nihon Naika Gakkai Zasshi; 2013 Jul; 102(7):1797-9. PubMed ID: 23947243
    [No Abstract]   [Full Text] [Related]  

  • 15. Systemic vasculitis in patients with hepatitis C virus infection with and without detectable mixed cryoglobulinemia.
    Terrier B; Sène D; Dechartres A; Saadoun D; Ortonne N; Rouvier P; Musset L; Rigon MR; Maisonobe T; Cacoub P
    J Rheumatol; 2011 Jan; 38(1):104-10. PubMed ID: 20952479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades.
    Holle JU; Gross WL; Latza U; Nölle B; Ambrosch P; Heller M; Fertmann R; Reinhold-Keller E
    Arthritis Rheum; 2011 Jan; 63(1):257-66. PubMed ID: 20862686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic vasculitis: study of 27 cases in Senegal].
    Ndongo S; Diallo S; Tiendrebeogo J; Diop IB; Tall A; Pouye A; Ka MM; Diop TM
    Med Trop (Mars); 2010 Jun; 70(3):264-6. PubMed ID: 20734595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
    Umsawasdi T; Nilprabhassorn P
    J Med Assoc Thai; 1978 Mar; 61(3):158-61. PubMed ID: 660008
    [No Abstract]   [Full Text] [Related]  

  • 19. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies.
    Jayne D; Rasmussen N; Andrassy K; Bacon P; Tervaert JW; Dadoniené J; Ekstrand A; Gaskin G; Gregorini G; de Groot K; Gross W; Hagen EC; Mirapeix E; Pettersson E; Siegert C; Sinico A; Tesar V; Westman K; Pusey C;
    N Engl J Med; 2003 Jul; 349(1):36-44. PubMed ID: 12840090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
    Raevskiĭ IG
    Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.